What is it about?
We describe the methods for a systematic review and meta-analysis of health state utility values for diabetic retinopathy. As no clear guidance is available for such studies, we also discuss a number of methodological issues.
Featured Image
Why is it important?
Model-based economic evaluation relies on representative parameters for health-related quality of life. Systematic review and meta-analysis is a means of considering all available evidence to inform model parameters and can reduce biased estimates of cost-effectiveness. A meta-analysis of health state utility values for diabetic retinopathy has never been conducted.
Perspectives
Lots of model-based evaluations have been conducted for interventions for diabetic retinopathy, and nearly all of them use just a couple of references for health state utility values. These studies might not be relevant to the modern decision context and there may be better sources available, so a review and meta-analysis is timely. I hope that our study will help to inform the development of guidance for future studies of this nature.
Mr Christopher James Sampson
The Office of Health Economics
Read the Original
This page is a summary of: Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis, Systematic Reviews, February 2015, Springer Science + Business Media,
DOI: 10.1186/s13643-015-0006-6.
You can read the full text:
Contributors
The following have contributed to this page
